Literature DB >> 16264411

Familial occurrence of adrenocortical insufficiency in two brothers with Allgrove syndrome. A case report of 4A (Allgrove) syndrome with epilepsy and a new AAAS gene mutation.

Egon Kurca1, M Grofik, Pavol Kucera, Pavel Varsik.   

Abstract

Allgrove syndrome is a rare autosomal recessive disease with achalasia, alacrima, adrenocortical insufficiency, autonomic neuropathy and other neurological disturbances. A case of two brothers with Addison s disease from early childhood is presented. The younger brother with Addison disease died at the age of 5. The older brother was treated for adrenocortical insufficiency from the age 3, and then treated for achalasia and epilepsy from the age of 5. The patient is currently 26 years old and suffers from achalasia and adrenocortical insufficiency. He also suffers from alacrima, autonomic neuropathy, epilepsy and other damages of the central and peripheral nervous system. The clinical picture is typical for Allgrove or 4A syndrome, and the diagnosis was confirmed by means of molecular analysis of a new AAAS gene mutation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16264411

Source DB:  PubMed          Journal:  Neuro Endocrinol Lett        ISSN: 0172-780X            Impact factor:   0.765


  3 in total

1.  Triple A syndrome: 32 years experience of a single centre (1977-2008).

Authors:  Tatjana Milenkovic; Dragan Zdravkovic; Natasa Savic; Sladjana Todorovic; Katarina Mitrovic; Katrin Koehler; Angela Huebner
Journal:  Eur J Pediatr       Date:  2010-05-25       Impact factor: 3.183

2.  Premature Loss of Permanent Teeth in Allgrove (4A) Syndrome in Two Related Families.

Authors:  Zahra Razavi; Mohammad-Mehdi Taghdiri; Fatemeh Eghbalian; Nooshin Bazzazi
Journal:  Iran J Pediatr       Date:  2010-03       Impact factor: 0.364

3.  Identifying and Analyzing Novel Epilepsy-Related Genes Using Random Walk with Restart Algorithm.

Authors:  Wei Guo; Dong-Mei Shang; Jing-Hui Cao; Kaiyan Feng; Yi-Chun He; Yang Jiang; ShaoPeng Wang; Yu-Fei Gao
Journal:  Biomed Res Int       Date:  2017-02-01       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.